###begin article-title 0
###xml 71 76 <span type="species:ncbi:9606">human</span>
TGF-beta-induced interleukin-6 participates in transdifferentiation of human Tenon's fibroblasts to myofibroblasts
###end article-title 0
###begin p 1
The first two authors contributed equally to this study.
###end p 1
###begin title 2
Purpose
###end title 2
###begin p 3
To gain a better understanding of the roles of interleukins (ILs) in subconjunctival fibrosis, we investigated their expression in transforming growth factor-beta1 (TGF-beta1)-stimulated Tenon's fibroblasts and examined their association with the transdifferentiation of fibroblasts to myofibroblasts.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 372 376 361 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 381 386 370 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 441 445 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 450 455 439 444 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 48 53 <span type="species:ncbi:9606">human</span>
After primary culture, fibroblasts derived from human Tenon's capsule were exposed to TGF-beta1. The expression of alpha-smooth muscle actin (alpha-SMA) protein was assessed by western immunoblots and immunofluorescence. The mRNA levels of various ILs were also evaluated by multiplex reverse transcription (RT)-PCR. Using the small interfering RNAs (siRNAs) specific for IL-6 and IL-11 and the promoter deletion assay, the contributions of IL-6 and IL-11 to TGF-beta1-induced induction of alpha-SMA were determined.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 161 165 154 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 170 175 163 168 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 344 348 333 337 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 384 389 373 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 441 445 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 3 8 <span type="species:ncbi:9606">human</span>
In human Tenon's fibroblasts, TGF-beta1 stimulated the expression of alpha-SMA protein determined by western blot analysis and also increased the mRNA levels of IL-6 and IL-11 determined by multiplex RT-PCR. On the western immunoblots and immunofluorescence, the increased expression of alpha-SMA was attenuated only by the siRNAs specific for IL-6 but not by the siRNAs specific for IL-11. When the activator protein-1 binding sites of the IL-6 promoter region were deleted, the stimulation effects of TGF-beta1 decreased.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 99 104 <span type="species:ncbi:9606">human</span>
Our data show that autocrine IL-6 may participate in the TGF-beta1-induced transdifferentiation of human Tenon's fibroblasts to myofibroblasts, which is known to be an essential step for subconjunctival fibrosis.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 288 289 288 289 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 290 291 290 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
###xml 399 400 393 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r7">7</xref>
###xml 401 402 395 396 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r9">9</xref>
###xml 643 645 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r10">10</xref>
###xml 646 648 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r14">14</xref>
###xml 149 157 <span type="species:ncbi:9606">patients</span>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
Subconjunctival fibrosis is an essential wound-healing process of the ocular surface, but if excessive it can result in ocular morbidity, as seen in patients with oculocutaneous disorders, such as ocular cicatricial pemphigoid, and patients who have undergone glaucoma-filtering surgery [1-6]. Even though transforming growth factor-beta (TGF-beta) is known to play a crucial role in this fibrosis [7-9], detailed mechanisms of how it functions have not yet been elucidated. Several recently published research papers that demonstrated antifibrotic effects of anti-TGF-beta molecules have re-stimulated interest in TGF-beta-mediated fibrosis [10-14].
###end p 11
###begin p 12
###xml 254 256 251 253 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 257 259 254 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 671 673 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r19">19</xref>
###xml 112 117 <span type="species:ncbi:9606">human</span>
In the present study, we were interested in investigating the relationship between inflammation and fibrosis in human Tenon's fibroblasts. In lung and heart, certain types of inflammation recruit and stimulate fibroblasts in a TGF-beta-dependent manner [15-18]. These activated fibroblasts then transdifferentiate to myofibroblasts that produce extracellular matrix (ECM); these contractile cells ultimately cause extensive fibrosis. In this study we investigated which of the proinflammatory cytokines of the interleukin (IL) family are stimulated by TGF-beta1, and we monitored changes in alpha-smooth muscle actin (alpha-SMA), a phenotypic hallmark of myofobroblasts [19], to investigate the effect of the TGF-beta1-stimulated ILs on the transdifferentiation of fibroblasts to myofibroblasts. The effects of blocking these ILs with small interfering RNA (siRNA) were also investigated.
###end p 12
###begin title 13
Methods
###end title 13
###begin title 14
Cell culture
###end title 14
###begin p 15
###xml 827 828 820 821 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 83 88 <span type="species:ncbi:9606">human</span>
###xml 237 249 <span type="species:ncbi:9606">participants</span>
###xml 634 638 <span type="species:ncbi:9913">calf</span>
After obtaining approval from the Institutional Review Board of our institution, 6 human Tenon's capsule specimens were excised during strabismus surgeries in compliance with the provisions of the Declaration of Helsinki. A total of six participants who have no other disease except strabismus and no previous ocular surgery/trauma history were included. Written informed consent was obtained before operative excision. Briefly, 5x5-mm sections of Tenon's capsule were collected, minced, and placed in a 35-mm culture dish containing Dulbecco's modified Eagle's medium (DMEM; Invitrogen Co., Carlsbad, CA) supplemented with 10% fetal calf serum (Invitrogen), and 50 U/ml penicillin and 50 mug/ml streptomycin (Invitrogen). Cells were allowed to migrate from the explanted tissue and were then incubated at 37 degreesC and 5% CO2. Cells between the third and fifth passages were used for this study. Cultures were allowed to reach about 80% confluence. Depending on the experiments, fibroblasts were treated with various concentrations of TGF-beta1 (R&D System, Minneapolis, MN) after 24 h of serum starvation in serum-free DMEM.
###end p 15
###begin title 16
Western immunoblot analysis
###end title 16
###begin p 17
###xml 124 126 124 126 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r20">20</xref>
###xml 239 240 239 240 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 75 80 <span type="species:ncbi:9606">human</span>
###xml 674 679 <span type="species:ncbi:9606">human</span>
###xml 863 874 <span type="species:ncbi:3704">horseradish</span>
Whole cellular proteins were isolated from primary cultured fibroblasts of human Tenon's capsules, as described previously [20]. Briefly, total cell lysates were obtained by using lysis buffer (25 mM HEPES [pH 7.5], 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.05% Triton X-100, 0.5 mM dithiothreitol [DTT], and 0.4 mM phenylmethylsulfonyl fluoride [PMSF]; Sigma-Aldrich, Co., St. Louis, MO), 2 mug/ml leupeptin (Sigma-Aldrich), and 2 mug/ml aprotinin (Sigma-Aldrich). Equal amounts of protein (20 mug) were subjected to sodium dodecyl sulfate polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. Membranes were probed with primary antibodies against human alpha-SMA (diluted 1:500; Dako Corporation, Carpinteria, CA) and beta-actin (diluted 1:5,000; Santa Cruz Biotechnology, Inc., Santa Cruz, CA). Immunoreactive bands were detected with horseradish peroxidase-conjugated secondary antibodies (diluted 1:5,000; Invitrogen) and visualized by enhanced chemiluminescence detection reagents on autoradiograph films.
###end p 17
###begin title 18
Multiplex reverse transcription-PCR
###end title 18
###begin p 19
###xml 291 293 291 293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r21">21</xref>
###xml 294 296 294 296 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r22">22</xref>
###xml 346 355 346 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1&#945;</italic>
###xml 357 365 353 358 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1&#946;</italic>
###xml 367 371 360 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-2</italic>
###xml 373 377 366 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-3</italic>
###xml 379 383 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-4</italic>
###xml 385 389 378 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-5</italic>
###xml 391 395 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 397 401 390 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-7</italic>
###xml 403 407 396 400 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-8</italic>
###xml 409 413 402 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-9</italic>
###xml 415 420 408 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 422 427 415 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 429 435 422 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12A</italic>
###xml 437 443 430 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12B</italic>
###xml 445 450 438 443 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-13</italic>
###xml 452 457 445 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-15</italic>
###xml 459 464 452 457 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-16</italic>
###xml 466 471 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-18</italic>
###xml 503 509 496 502 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 542 552 535 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 575 581 562 565 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;2M</italic>
###xml 626 631 610 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 677 681 661 665 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDHA</italic>
###xml 712 718 696 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPL13a</italic>
Total RNA was extracted from fibroblasts and converted into complementary (c)DNA by a first-strand synthesis system (SuperScript III; Invitrogen). Subsequently, the cDNA was used as a template for multiplex reverse transcription (RT)-PCR assays (MegaXpression; Seegene, Inc., Seoul, Korea) [21,22]. The following IL gene segments were amplified: IL-1alpha, IL-1beta, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-11, IL-12A, IL-12B, IL-13, IL-15, IL-16, IL-18, and IL-1 receptor antagonist (IL-1RN). In addition, gene segments of beta-actin, beta2-microblobulin (beta2M), glyceraldehyde-3-phosphate dehydrogenase (GAPDH), succinate dehydrogenase complex subunit A (SDHA), and ribosomal protein L13a (RPL13a) were amplified as housekeeping genes.
###end p 19
###begin title 20
RNA interference assay
###end title 20
###begin p 21
###xml 26 30 26 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 35 40 35 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 116 120 116 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 258 263 258 263 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
siRNA molecules targeting IL-6 and IL-11 mRNA were purchased from Ambion, Inc. (Austin, TX). The RNA duplex against IL-6 had the sequence 5'-GGA CAU GAC AAC UCA UCU CTT-3' (sense) and 5'-GAG AUG AGU UGU CAU GUC CTG-3' (antisense); and the RNA duplex against IL-11 had the sequence 5'-GCA ACA UGG UGC AUC UGU GTT-3' (sense) and 5'-CAC AGA UGC ACC AUG UUG CTT-3' (antisense). siRNAs were delivered into cells according to the manufacturer's instructions. Briefly, the diluted transfection reagent (siPORT Amine; Ambion) was mixed with the diluted siRNA to allow the formation of transfection complexes. This mixture with a final RNA concentration of 20 nM was then dispensed onto the cells and incubated for 24 h.
###end p 21
###begin title 22
Immunofluorescence analysis
###end title 22
###begin p 23
###xml 221 226 <span type="species:ncbi:9606">human</span>
To carry out immunostaining, fibroblasts were fixed in 4% paraformaldehyde for 5 min and permeabilized in 0.2% Triton X-100 for 5 min at room temperature. Fibroblasts were then incubated with the primary antibody against human alpha-SMA (diluted 1:50) overnight at 4 degreesC and probed with a fluoroscein isothiocyanate-conjugated secondary antibody (diluted 1:100) for 2 h at room temperature in the dark. Subsequently, they were washed and viewed by immunofluorescence microscopy (IX71; Olympus, Tokyo, Japan).
###end p 23
###begin title 24
Cell transfection and luciferase assay
###end title 24
###begin p 25
###xml 117 121 117 121 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r23">23</xref>
###xml 481 483 481 483 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r24">24</xref>
###xml 111 116 <span type="species:ncbi:9606">human</span>
Three recombinant plasmids, in which different fragments of the activator protein-1 (AP-1)-binding site of the human IL-6 promoter were deleted (p1168hu.IL6P-luc+, wild type; p1168h.IL6m3AP1-luc+, 3'-terminal deletion; and p1168h.IL6m5AP1-luc+, 5'-terminal deletion), were used as reporter constructs. These plasmids were obtained from the Belgian Coordinated Collections of Microorganism (BCCM/LMBP) Plasmid Collection (Zwijnaarde, Belgium) and have been described previously [23,24].
###end p 25
###begin p 26
Cells were transfected with an equal amount of reporter plasmid using Lipofectamine 2000 (Invitrogen). The luciferase activities were determined using a luciferase assay system (Promega, Co., Madison, WI), following the manufacturer's instruction. Briefly, the 96-well plate containing 20 mul of cell lysate per well was placed into the luminometer with injector. The injector added 100 mul of luciferase assay reagent per well, then the well was read immediately. The plate was advanced to the next well for a repeat of the inject-then-read process. The typical delay time was 2 s and the typical read time was 10 s.
###end p 26
###begin title 27
Data analysis
###end title 27
###begin p 28
###xml 156 157 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">U</italic>
Densitometric data are expressed as means +/- standard deviation (SD). Data were compared with Kruskal-Wallis one-way analysis of variance and Mann-Whitney U test using the SPSS program for Windows, version 12.0.1 (SPSS Inc., Chicago, IL). A p value less than 0.05 was considered statistically significant.
###end p 28
###begin title 29
Results
###end title 29
###begin title 30
Transforming growth factor-beta1 induces transdifferentiation of fibroblasts to myofibroblasts
###end title 30
###begin p 31
###xml 326 334 305 313 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f1">Figure 1</xref>
###xml 108 113 <span type="species:ncbi:9606">human</span>
To evaluate the effect of TGF-beta1 on the expression of alpha-SMA, we measured alpha-SMA protein levels in human Tenon's fibroblasts stimulated with different concentrations of TGF-beta1 for different durations. Exposure of fibroblasts to TGF-beta1 resulted in a dose- and time-dependent increase in expression of alpha-SMA (Figure 1). TGF-beta1 treatment (10 ng/ml) for 72 h resulted in a significant increase (p<0.001) in alpha-SMA expression. Because the presence of alpha-SMA is a phenotypic hallmark of myofobroblasts, this finding indicates that TGF-beta1 induced the transdifferentiation of fibroblasts to myofibroblasts.
###end p 31
###begin p 32
###xml 65 66 61 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 194 195 187 188 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
Representative western blot bands for alpha-smooth muscle actin. A: Dose-response effects: fibroblasts were exposed to various concentrations of transforming growth factor (TGF)-beta1 for 72 h. B: Time-response effects: fibroblasts were incubated with or without 10 ng/ml of TGF-beta1 for up to 6 days. beta-actin was used as an internal control. Densitimetric data represent the mean+/-SD of results from three independent experiments.
###end p 32
###begin title 33
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 25 30 25 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
Upregulation of IL-6 and IL-11 by transforming growth factor-beta1 treatment
###end title 33
###begin p 34
###xml 295 301 286 292 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1RN</italic>
###xml 303 312 294 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1&#945;</italic>
###xml 314 318 301 305 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-2</italic>
###xml 320 324 307 311 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-3</italic>
###xml 326 330 313 317 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-4</italic>
###xml 332 336 319 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-5</italic>
###xml 342 346 329 333 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 354 358 341 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 402 411 389 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2A</xref>
###xml 443 447 430 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-7</italic>
###xml 449 454 436 441 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-10</italic>
###xml 456 461 443 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 463 469 450 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12B</italic>
###xml 471 476 458 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-13</italic>
###xml 478 483 465 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-15</italic>
###xml 489 494 476 481 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-16</italic>
###xml 502 507 489 494 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 551 560 538 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2B</xref>
###xml 577 585 564 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-1&#946;</italic>
###xml 587 591 571 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-8</italic>
###xml 593 597 577 581 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-9</italic>
###xml 599 605 583 589 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-12A</italic>
###xml 611 616 595 600 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-18</italic>
###xml 673 683 657 664 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;-actin</italic>
###xml 685 691 666 669 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;2M</italic>
###xml 693 698 671 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 700 704 678 682 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SDHA</italic>
###xml 710 716 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPL13a</italic>
###xml 750 759 725 734 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f2">Figure 2C</xref>
###xml 829 833 801 805 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 838 843 810 815 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 103 108 <span type="species:ncbi:9606">human</span>
###xml 847 852 <span type="species:ncbi:9606">human</span>
To assess the effect of TGF-beta1 on the transcription of ILs, the IL mRNA levels in TGF-beta1-treated human Tenon's fibroblasts were evaluated using multiplex RT-PCR. After fibroblasts were incubated with 10 ng/ml TGF-beta1 for 72 h, multiplex RT-PCR was performed. For the first set of genes (IL-1RN, IL-1alpha, IL-2, IL-3, IL-4, IL-5, and IL-6), only IL-6 mRNA was increased significantly (p<0.001; Figure 2A); for the second set of genes (IL-7, IL-10, IL-11, IL-12B, IL-13, IL-15, and IL-16), only IL-11 mRNA was increased significantly (p<0.001; Figure 2B). The levels of IL-1beta, IL-8, IL-9, IL-12A, and IL-18 were not changed (data not shown) and the expression of beta-actin, beta2M, GAPDH, SDHA, and RPL13a was not influenced by TGF-beta1 (Figure 2C). These data demonstrate that TGF-beta1 induces the transcription of IL-6 and IL-11 in human Tenon's fibroblasts.
###end p 34
###begin p 35
###xml 101 102 101 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 104 105 104 105 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 131 132 131 132 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 366 371 360 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">GAPDH</italic>
###xml 414 421 408 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> IL-1RN</italic>
###xml 458 464 452 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">RPL13a</italic>
###xml 465 470 459 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"> SDHA</italic>
###xml 515 521 509 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#946;2M</italic>
###xml 617 621 605 609 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 626 631 614 619 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
Multiplex reverse transcription PCR. Multiplex reverse transcription PCR sets for interleukins (ILs; A, B) and housekeeping genes (C). For each set of data, lane 1 represents the control group with no transforming growth factor (TGF)-beta1 treatment and lane 2 represents the study group with 10 ng/ml TGF-beta1 treatment for 72 h. Lane M contains positive markers. GAPDH, glyceraldehyde-3-phosphate dehydrogenase; IL-1RN, interleukin-1 receptor antagonist; RPL13a; SDHA, succinate dehydrogenase complex subunit A; beta2M, beta2-microblobulin. Two asterisks refer to a significant increase (p<0.001) in expression of IL-6 and IL-11 in the presence of TGF-beta1.
###end p 35
###begin title 36
###xml 95 99 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
Transforming growth factor-beta1-induced expression of alpha-smooth muscle actin is reduced by IL-6-specific small interfering RNAs
###end title 36
###begin p 37
###xml 153 157 150 154 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 162 167 159 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 320 324 317 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 330 335 327 332 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 431 435 421 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 515 524 498 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3A</xref>
###xml 535 540 518 523 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 576 585 559 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f3">Figure 3B</xref>
To more directly address the possible involvement of IL-6 and IL-11 in TGF-beta1-induced myofibroblast transdifferentiation, we evaluated the effects of IL-6 and IL-11 knockdown using specific siRNAs. Since the accumulation of ECM proteins is an indicator of myofibroblast transdifferentiation, we studied the effect of IL-6- and IL-11-specific siRNAs on TGF-beta1-induced expression of the ECM component alpha-SMA. Treatment with IL-6-specific siRNAs strongly inhibited the TGF-beta1-induced alpha-SMA expression (Figure 3A), whereas IL-11-specific siRNAs had little effect (Figure 3B).
###end p 37
###begin p 38
###xml 27 31 27 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 36 41 36 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 96 100 96 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 102 103 102 103 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 109 114 109 114 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 116 117 116 117 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
RNA interference assay for IL-6 and IL-11. After administering small interfering RNAs targeting IL-6 (A) and IL-11 (B), fibroblasts were exposed to 10 ng/ml transforming growth factor (TGF)-beta1 for 72 h. Then, the expression of alpha-smooth muscle actin (alpha-SMA) was evaluated using western blots. Densitimetric data represent the mean+/-SD of results from three independent experiments. The asterisks refer to a significant difference compared to TGF-beta treatment only (p<0.001).
###end p 38
###begin p 39
###xml 52 56 52 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 62 67 62 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 221 229 214 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4</xref>
###xml 396 405 382 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4B</xref>
###xml 437 441 423 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 541 550 520 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4D</xref>
###xml 633 638 608 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 656 665 631 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f4">Figure 4F</xref>
###xml 709 713 684 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
To confirm this finding, we assessed the effects of IL-6- and IL-11-specific siRNAs on TGF-beta1-induced alpha-SMA upregulation by immunofluorescent staining and obtained similar results with western immunoblot analysis (Figure 4). Compared to untreated control fibroblasts, TGF-beta1-stimulated fibroblasts showed a strong cytoplasmic alpha-SMA signal with numerous intracellular stress fibers (Figure 4B). Fibroblasts transfected with IL-6-specific siRNAs showed a significant reduction in the effect of TGF-beta1 on alpha-SMA expression (Figure 4D); but cytoplasmic staining for alpha-SMA was little diminished in the presence of IL-11-specific siRNAs (Figure 4F). These data demonstrate that knockdown of IL-6 reduces the ability of TGF-beta1 to induce alpha-SMA expression.
###end p 39
###begin p 40
###xml 75 76 71 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">A</bold>
###xml 100 101 96 97 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">B</bold>
###xml 161 162 154 155 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">C</bold>
###xml 164 168 157 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 205 206 198 199 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">D</bold>
###xml 208 212 201 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 262 263 252 253 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">E</bold>
###xml 265 270 255 260 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 291 292 281 282 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">F</bold>
###xml 294 299 284 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
Immunofluorescent analysis of the expression of alpha-smooth muscle actin. A: No treatment control, B: 10 ng/ml transforming growth factor (TGF)-beta1 for 72 h, C: IL-6-specific small interfering (si)RNA, D: IL-6-specific siRNA plus 10 ng/ml TGF-beta1 for 72 h, E: IL-11-specific siRNA, and F: IL-11-specific siRNA plus 10 ng/ml TGF-beta1 for 72 h. The secondary antibody was conjugated with fluoroscein isothiocyanate, resulting in green fluorescence. Total magnification was 400x.
###end p 40
###begin title 41
###xml 36 40 36 40 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
Activator protein-1 activity at the IL-6 promoter in the presence of transforming growth factor-beta1
###end title 41
###begin p 42
###xml 134 138 131 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 183 187 180 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 228 232 225 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 252 260 249 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="f5">Figure 5</xref>
###xml 458 462 452 456 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 684 688 672 676 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
To determine whether TGF-beta1-mediated myofibroblast transdifferentiation might be related to AP-1-binding site-dependent effects on IL-6 transcription, we used wild-type and mutant IL-6 promoter-reporter constructs to analyze IL-6 promoter activity (Figure 5). TGF-beta1 increased the promoter activity of the wild-type-reported plasmid about 2.5-fold above the no-treatment control (p<0.001). However when the 3' or 5' end of the AP-1-binding site of the IL-6 promoter was deleted, the increased promoter activity by TGF-beta1 was significantly attenuated (p<0.001). Our results indicate that the effect of TGF-beta1 on IL-6 expression is dependent on the AP-1-binding site of the IL-6 promoter region and suggest that TGF-beta1-induced myofibroblast transdifferentiation is dependent, at least in part, on TGF-beta1-induced IL-6 expression.
###end p 42
###begin p 43
###xml 43 47 43 47 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 167 171 167 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 161 166 <span type="species:ncbi:9606">human</span>
Promoter deletion assay for interleukin-6 (IL-6). Three recombinant plasmids, in which different fragments of the activator protein-1 (AP-1)-binding site on the human IL-6 promoter were deleted, were used. After transfection with each plasmid, fibroblasts were incubated with 10 ng/ml transforming growth factor (TGF)-beta1 for 72 h. The luciferase activity was then determined and expressed as the percent of the no-TGF-beta1 treatment control. Data represent the mean+/-SD of results from three independent experiments. The asterisks refer to a significant difference (p<0.001) compared to the wild type.
###end p 43
###begin title 44
Discussion
###end title 44
###begin p 45
###xml 368 369 368 369 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r1">1</xref>
###xml 370 371 370 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r6">6</xref>
Transdifferentiation of fibroblasts to myofibroblasts is at the core of the fibrotic process. Although the fibrosis caused by these activated fibroblasts is essential for natural wound healing, it can also result in excessive scarring, which is one of the most common causes of surgical failure after various ocular surgeries, including glaucoma-filtering procedures [1-6]. Although adjunctive antimetabolites can suppress the proliferation of fibroblasts and reduce subconjunctival fibrosis, the use of these compounds may result in serious complications; thus a new treatment strategy to prevent excessive fibrosis is required.
###end p 45
###begin p 46
###xml 165 167 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r15">15</xref>
###xml 168 170 165 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r18">18</xref>
###xml 255 257 249 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r25">25</xref>
###xml 258 260 252 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r29">29</xref>
In various organs, including the lung and heart, inflammation is known to result in the development of fibrosis; TGF-beta seems to be at the center of this process [15-18]. At the ocular surface, TGF-beta plays a key role as a potent fibrogenic cytokine [25-29]. It is thought to stimulate the chemotaxis and transdifferentiation of fibroblasts, resulting in the overproduction of collagen, fibronectin, and other ECM components. Furthermore, TGF-beta reduces the degradation of synthesized ECM through suppression of the activity of matrix metalloproteases and the activation of protease inhibitors.
###end p 46
###begin p 47
###xml 69 71 69 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r30">30</xref>
###xml 72 74 72 74 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r33">33</xref>
###xml 350 352 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r34">34</xref>
IL-6 is essentially a chemoattractant and stimulator of lymphocytes [30-33]. It also functions as a pleiotropic mediator in the acute-phase response and stimulates the differentiation and proliferation of various target cells [33]. IL-6 exerts its effects through the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway [34]. Because the IL-6 receptor does not have intrinsic tyrosine kinase activity, when IL-6 binds to the extracellular ligand-binding domain of its receptor, members of the JAK family are activated and phosphorylate the tyrosine residues of the IL-6 receptor, which then act as docking sites for the SH2 domains of STATs. IL-6-activated T lymphocytes then secrete TGF-beta and trigger the fibrotic cascade.
###end p 47
###begin p 48
###xml 144 146 144 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="r35">35</xref>
Consistent with a previous report that IL-6 participates directly in the transdifferentiation of Tenon's capsule fibroblasts to myofibroblasts [35], in the present study we verified the presence of autocrine IL-6 from activated Tenon's capsule fibroblasts.
###end p 48
###begin p 49
###xml 35 39 35 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 44 49 44 49 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 198 202 191 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-6</italic>
###xml 332 337 318 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-11</italic>
###xml 92 97 <span type="species:ncbi:9606">human</span>
###xml 454 459 <span type="species:ncbi:9606">human</span>
We found that the transcription of IL-6 and IL-11 was increased by TGF-beta1 stimulation in human Tenon's fibroblasts, and that this was accompanied by the upregulated expression of alpha-SMA. When IL-6-specific siRNAs were used, the TGF-beta1-stimulated increase in expression of alpha-SMA was blocked, but this did not occur when IL-11-specific siRNAs were used. Our results indicate that autocrine IL-6 produced as a result of TGF-beta-stimulation of human Tenon's fibroblasts stimulates the transdifferentiation of these fibroblasts to myofibroblasts, which is thought to be essential for subconjunctival fibrosis. Modulation of autocrine IL-6 production might be useful as a novel therapeutic strategy for controlling postoperative subconjunctival fibrosis.
###end p 49
###begin title 50
Acknowledgments
###end title 50
###begin p 51
This work was supported by a Faculty Research Grant from Yonsei University College of Medicine (6-2008-0156).
###end p 51
###begin title 52
References
###end title 52
###begin article-title 53
Wound healing in glaucoma filtering surgery.
###end article-title 53
###begin article-title 54
###xml 41 49 <span type="species:ncbi:9606">patients</span>
Collagen abnormalities in conjunctiva of patients with cicatricial pemphigoid.
###end article-title 54
###begin article-title 55
Role of collagen-binding heat shock protein 47 and transforming growth factor-beta1 in conjunctival scarring in ocular cicatricial pemphigoid.
###end article-title 55
###begin article-title 56
###xml 85 91 <span type="species:ncbi:9986">rabbit</span>
Expression of connective tissue growth factor after glaucoma filtration surgery in a rabbit model.
###end article-title 56
###begin article-title 57
Expression of bone morphogenetic proteins (BMPs), their receptors, and activins in normal and scarred conjunctiva: role of BMP-6 and activin-A in conjunctival scarring?
###end article-title 57
###begin article-title 58
###xml 59 67 <span type="species:ncbi:9606">patients</span>
Conjunctival in vivo confocal scanning laser microscopy in patients with atopic keratoconjunctivitis.
###end article-title 58
###begin article-title 59
TGF-beta1, -beta2, and -beta3 in vitro: biphasic effects on Tenon's fibroblast contraction, proliferation, and migration.
###end article-title 59
###begin article-title 60
###xml 91 96 <span type="species:ncbi:9606">human</span>
Contractility as a prerequisite for TGF-beta-induced myofibroblast transdifferentiation in human Tenon fibroblasts.
###end article-title 60
###begin article-title 61
Localization of TGF-beta type II receptor and ED-A fibronectin in normal conjunctiva and failed filtering blebs.
###end article-title 61
###begin article-title 62
###xml 0 5 <span type="species:ncbi:9606">Human</span>
Human antitransforming growth factor beta(2) monoclonal antibody--a new modulator of wound healing in trabeculectomy: a randomized placebo controlled clinical study.
###end article-title 62
###begin article-title 63
RNA interference targeting transforming growth factor-beta type II receptor suppresses ocular inflammation and fibrosis.
###end article-title 63
###begin article-title 64
Sustained release of nanosized complexes of polyethylenimine and anti-TGF-beta 2 oligonucleotide improves the outcome of glaucoma surgery.
###end article-title 64
###begin article-title 65
###xml 37 42 <span type="species:ncbi:9606">human</span>
A phase III study of subconjunctival human anti-transforming growth factor beta(2) monoclonal antibody (CAT-152) to prevent scarring after first-time trabeculectomy.
###end article-title 65
###begin article-title 66
Factors affecting the outcome of trabeculectomy: an analysis based on combined data from two phase III studies of an antibody to transforming growth factor beta2, CAT-152.
###end article-title 66
###begin article-title 67
Roles for insulin-like growth factor I and transforming growth factor-beta in fibrotic lung disease.
###end article-title 67
###begin article-title 68
###xml 120 125 <span type="species:ncbi:10090">mouse</span>
Change in the cells that express connective tissue growth factor in acute Coxsackievirus-induced myocardial fibrosis in mouse.
###end article-title 68
###begin article-title 69
Fibroblast migration is mediated by CD44-dependent TGF beta activation.
###end article-title 69
###begin article-title 70
Heterogeneous response of nasal and lung fibroblasts to transforming growth factor-beta 1.
###end article-title 70
###begin article-title 71
Alpha-smooth muscle actin expression upregulates fibroblast contractile activity.
###end article-title 71
###begin article-title 72
###xml 102 107 <span type="species:ncbi:9606">human</span>
Upregulation of TGF-beta-induced tissue transglutaminase expression by PI3K-Akt pathway activation in human subconjunctival fibroblasts.
###end article-title 72
###begin article-title 73
Dual priming oligonucleotide system for the multiplex detection of respiratory viruses and SNP genotyping of CYP2C19 gene.
###end article-title 73
###begin article-title 74
###xml 41 58 <span type="species:ncbi:10407">hepatitis B virus</span>
Direct detection of lamivudine-resistant hepatitis B virus mutants by a multiplex PCR using dual-priming oligonucleotide primers.
###end article-title 74
###begin article-title 75
Recombination signal sequence binding protein Jkappa is constitutively bound to the NF-kappaB site of the interleukin-6 promoter and acts as a negative regulatory factor.
###end article-title 75
###begin article-title 76
p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-kappaB p65 transactivation mediated by tumor necrosis factor.
###end article-title 76
###begin article-title 77
A corneal epithelial inhibitor of stromal cell collagenase synthesis identified as TGF-beta 2.
###end article-title 77
###begin article-title 78
The control of matrix metalloproteinase-2 expression in normal and keratoconic corneal keratocyte cultures.
###end article-title 78
###begin article-title 79
Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring.
###end article-title 79
###begin article-title 80
Smad3 as a mediator of the fibrotic response.
###end article-title 80
###begin article-title 81
Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.
###end article-title 81
###begin article-title 82
###xml 95 100 <span type="species:ncbi:9606">human</span>
Interleukin 6 is the principal cytolytic T lymphocyte differentiation factor for thymocytes in human leukocyte conditioned medium.
###end article-title 82
###begin article-title 83
###xml 22 27 <span type="species:ncbi:9606">human</span>
Induction of in vitro human lymphocyte migration by interleukin 3, interleukin 4, and interleukin 6.
###end article-title 83
###begin article-title 84
Tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in B-lymphocyte function.
###end article-title 84
###begin article-title 85
Interleukin-6 signal transduction and lymphocyte function.
###end article-title 85
###begin article-title 86
The JAK/STAT signaling pathway.
###end article-title 86
###begin article-title 87
Antiglaucoma eye drop pulses--increased interleukin-6 secretion by Tenon's capsule fibroblast cultures.
###end article-title 87

